Pablo Cano

738 total citations
12 papers, 544 citations indexed

About

Pablo Cano is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Pablo Cano has authored 12 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Pablo Cano's work include Alkaloids: synthesis and pharmacology (4 papers), Traditional and Medicinal Uses of Annonaceae (4 papers) and Cancer Genomics and Diagnostics (3 papers). Pablo Cano is often cited by papers focused on Alkaloids: synthesis and pharmacology (4 papers), Traditional and Medicinal Uses of Annonaceae (4 papers) and Cancer Genomics and Diagnostics (3 papers). Pablo Cano collaborates with scholars based in Canada, United States and Peru. Pablo Cano's co-authors include John T. Arnason, Robert M. Lafrenie, Colin Germond, Paweł Zalewski, John A. Stewart, Scot Dowden, Malcolm J. Moore, Muhammad Zulfiqar, Sukhbinder Dhesy‐Thind and Sharlene Gill and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Ethnopharmacology.

In The Last Decade

Pablo Cano

12 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Cano Canada	9	283	153	130	127	114	12	544
Liangliang Bai China	17	251 0.9×	156 1.0×	70 0.5×	348 2.7×	141 1.2×	51	838
Radka Václavíková Czechia	15	204 0.7×	136 0.9×	79 0.6×	342 2.7×	103 0.9×	36	608
Jin Gao China	13	148 0.5×	173 1.1×	85 0.7×	291 2.3×	84 0.7×	23	661
Valérie Le Morvan France	18	310 1.1×	129 0.8×	124 1.0×	389 3.1×	113 1.0×	45	745
Wafaey Gomaa Saudi Arabia	14	179 0.6×	61 0.4×	55 0.4×	192 1.5×	71 0.6×	47	618
Quan Jiang China	15	169 0.6×	95 0.6×	43 0.3×	213 1.7×	115 1.0×	30	534
Xingkai Liu China	15	116 0.4×	97 0.6×	50 0.4×	366 2.9×	50 0.4×	39	692
Paola Gerletti United States	6	335 1.2×	172 1.1×	39 0.3×	190 1.5×	164 1.4×	9	915
George J. Tsioulias United States	19	549 1.9×	136 0.9×	31 0.2×	138 1.1×	159 1.4×	28	1.0k

Countries citing papers authored by Pablo Cano

Since Specialization

Citations

This map shows the geographic impact of Pablo Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Cano more than expected).

Fields of papers citing papers by Pablo Cano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Cano. The network helps show where Pablo Cano may publish in the future.

Co-authorship network of co-authors of Pablo Cano

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Cano. A scholar is included among the top collaborators of Pablo Cano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Cano. Pablo Cano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Abou‐Alfa, Ghassan K., Tim Meyer, Richard Kinh Gian, et al.. (2024). Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma. Liver Cancer. 14(1). 1–10. 1 indexed citations

Cano, Pablo, et al.. (2017). Uncaria tomentosa (Willd. ex Schult.) DC (Rubiaceae) sensitizes THP-1 cells to radiation-induced cell death. Pharmacognosy Research. 9(3). 221–221. 2 indexed citations

Gill, Sharlene, Yoo‐Joung Ko, C. Cripps, et al.. (2016). PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy. Journal of Clinical Oncology. 34(32). 3914–3920. 180 indexed citations

Gill, Sharlene, Yoo‐Joung Ko, M. Christine Cripps, et al.. (2014). PANCREOX: A randomized phase 3 study of 5FU/LV with or without oxaliplatin for second-line advanced pancreatic cancer (APC) in patients (pts) who have received gemcitabine (GEM)-based chemotherapy (CT).. Journal of Clinical Oncology. 32(15_suppl). 4022–4022. 37 indexed citations

Cano, Pablo, et al.. (2013). Recurrent renal cell cancer: 10 years or more after nephrectomy. Canadian Urological Association Journal. 4(2). 45–45. 13 indexed citations

Hu, Changkun, V. Raja Solomon, Pablo Cano, & Hoyun Lee. (2009). A 4-aminoquinoline derivative that markedly sensitizes tumor cell killing by Akt inhibitors with a minimum cytotoxicity to non-cancer cells. European Journal of Medicinal Chemistry. 45(2). 705–709. 29 indexed citations

Arnason, John T., et al.. (2009). Uncaria tomentosa acts as a potent TNF-α inhibitor through NF-κB. Journal of Ethnopharmacology. 127(3). 685–693. 51 indexed citations

Cano, Pablo, et al.. (2006). Treatment of THP-1 cells with Uncaria tomentosa extracts differentially regulates the expression if IL-1β and TNF-α. Journal of Ethnopharmacology. 109(2). 312–317. 48 indexed citations

Noble, Jonathan, et al.. (2006). Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors. Clinical Cancer Research. 12(10). 3092–3098. 89 indexed citations

10.

Germond, Colin, et al.. (2004). A phase II clinical trial involving the use of low-dose daily oral cyclophosphamide, weekly vinblastine and rofecoxib in patients with advanced solid tumors. Journal of Clinical Oncology. 22(14_suppl). 3137–3137. 1 indexed citations

11.

Lemaire, Irma, et al.. (1999). Stimulation of interleukin-1 and -6 production in alveolar macrophages by the neotropical liana, Uncaria tomentosa (Uña de Gato). Journal of Ethnopharmacology. 64(2). 109–115. 74 indexed citations

12.

Glück, Stefan, Colin Germond, Pedro López, et al.. (1998). A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer. European Journal of Cancer. 34(7). 1008–1014. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact